Study of Effect of Purgation therapy( virechan) on Serum IgE antibody Level In Atopic Dermatitis(Eczema)
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2024/06/069620
- Lead Sponsor
- Ayurvedic and Unani Tibbia college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patient with known case of atopic dermatitis along with specific symptomatology of
atopic dermatitis according to criteria of American academy dermatology of eczema
with increased IgE level .
2.Patient of Age group 18-60 years of either sex.
1.Patients who are contraindicated for virechana karma- like lower GI bleeding, Prolapse of rectum, incontinence of stool etc. will not be included in the trial group
2. Patients of other skin disorders (like psoriasis,seborrheic dermatitis ,scabies,contact dermatitis,lupus erythematous etc.) .
3. Patients with comorbid condition such as Diabetes mellitus(having HbA1c greater than 7.5 percent with or without antihyperglycemic medication).
4. Patients with renal or hepatic impairment (Sr. creatinine greater than 1.8 mg/dl, SGOT and SGPT greater than Five times of upper limit .
5. Patients who are taking immunomodulatory drug since last 2 month, antitubercular ,anti-retroviral drugs,steroids,antibiotics, etc .
6. Patients requiring emergency treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method